Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Caminati (Milano, MI, Italy). An epidemiological study on the effect of age, sex and comorbidities on the clinical course of idiopathic pulmonary fibrosis. 4882

Member's Comments

No comment yet.

Related content which might interest you: Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study Source: Annual Congress 2007 - The air we breathe at home and at work Year: 2007 The influence of smoking history on the prognosis of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Social position and mortality from respiratory diseases in males and females Source: Eur Respir J 2003; 21: 821-826 Year: 2003 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 The effect of smoking on lung function: a clinical study of adult-onset asthma Source: Eur Respir J 2016; 48: 1298-1306 Year: 2016 Prevalence of symptoms of chronic obstructive pulmonary disease among different gender and age groups according to the survey Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 The gender difference in smoking behavioral dependency in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis? Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Impact of age, age at diagnosis and duration of asthma on the risk of exacerbations in the EuroSMART study Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Regional and practice-based variations in the diagnosis of chronic obstructive pulmonary disease (COPD) unexplained by deprivation, population demographics, and practice list size Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 The impact of ethnicity on disease presentation and control in severe asthma Source: Virtual Congress 2021 – New evidence from longitudinal asthma cohorts and other key studies Year: 2021 Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Cross-sectional study on therapeutic adherence and disease knowledge of patients affected by chronic obstructive pulmonary disease. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006 Study of pulmonary embolism prevalence depending on age and sex by autopsy data Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020